Ritlecitinib
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 177 publications
Comment on "Ritlecitinib in Alopecia Areata: A 24-Week Real-World Experience Contrasting JAK Inhibitor-Naïve and JAK Inhibitor-Experienced Patients".
Journal: The Journal of dermatology
Published: December 31, 2025
Efficiency and safety of JAK inhibitors for alopecia totalis and alopecia universalis
Journal: Zhonghua yi xue za zhi
Published: December 16, 2025
Oral JΑΚ Inhibitors in Vitiligo Treatment.
Journal: Dermatology and therapy
Published: November 18, 2025
Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience.
Journal: Journal of cutaneous medicine and surgery
Published: November 11, 2025
Deuruxolitinib (Leqselvi) for severe alopecia areata.
Journal: The Medical letter on drugs and therapeutics
Published: October 21, 2025
Efficacy and safety of baricitinib treatment in alopecia areata: a retrospective analysis
Journal: Orvosi hetilap
Published: October 17, 2025
Beyond Hair Regrowth: Interpreting the Psychosocial Impact of Ritlecitinib in Alopecia Areata.
Journal: International journal of dermatology
Published: October 17, 2025
Therapeutic drug monitoring of Janus kinase inhibitors for precision dosing: where do we stand ?
Journal: Expert review of clinical pharmacology
Published: October 16, 2025
Real-world efficacy and safety of ritlecitinib combined with phototherapy in refractory vitiligo: A single-center experience.
Journal: Journal of the American Academy of Dermatology
Published: October 07, 2025
Ritlecitinib in Alopecia Areata: A 24-Week Real-World Experience Contrasting JAK Inhibitor-Naïve and JAK Inhibitor-Experienced Patients.
Journal: The Journal of dermatology
Published: October 05, 2025
Last Updated: 02/24/2026